This technology-based enterprise specializes in chemical generic drugs (including pharmaceutical APIs), biological products, and plasma products. They operate across multiple regions including the EU, North America, and others. Their key therapeutic areas focus on central nervous system disorders, metabolic disorders, infectious diseases, and autoimmune diseases. They offer a range of dosage forms including tablets, solutions for injection, and powders. The company holds GMP certifications and possesses several product patents.
Manufacturer usually replies in 6 days